project id: TCGA-UVM; case submitter id: TCGA-V4-A9EX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 9.1; age at index: 55; days to birth: -20447; days to death: 730; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1957; year of death: 2014; age at diagnosis: 20447; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8771/3; primary diagnosis: Epithelioid cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 606; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-V4-A9EX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;